KLSE (MYR): ALPHA (0303)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.325
Today's Change
0.00 (0.00%)
Day's Change
0.32 - 0.325
Trading Volume
1,165,200
Market Cap
1,583 Million
NOSH
4,871 Million
Latest Quarter
30-Nov-2024 [#2]
Announcement Date
21-Jan-2025
Next Quarter
28-Feb-2025
Est. Ann. Date
21-Apr-2025
Est. Ann. Due Date
29-Apr-2025
QoQ | YoY
5.00% | 23.63%
Revenue | NP to SH
173,687.000 | 57,078.000
RPS | P/RPS
3.57 Cent | 9.11
EPS | P/E | EY
1.17 Cent | 27.74 | 3.61%
DPS | DY | Payout %
0.90 Cent | 2.77% | 76.91%
NAPS | P/NAPS
0.04 | 8.13
QoQ | YoY
5.33% | 367.32%
NP Margin | ROE
33.57% | 29.30%
F.Y. | Ann. Date
30-Nov-2024 | 21-Jan-2025
Latest Audited Result
31-May-2024
Announcement Date
30-Sep-2024
Next Audited Result
31-May-2025
Est. Ann. Date
30-Sep-2025
Est. Ann. Due Date
27-Nov-2025
Revenue | NP to SH
167,586.000 | 52,933.000
RPS | P/RPS
3.44 Cent | 9.45
EPS | P/E | EY
1.09 Cent | 29.91 | 3.34%
DPS | DY | Payout %
0.70 Cent | 2.15% | 64.27%
NAPS | P/NAPS
0.04 | 8.14
YoY
null%
NP Margin | ROE
32.26% | 27.23%
F.Y. | Ann. Date
31-May-2024 | 17-Jul-2024
Revenue | NP to SH
172,478.000 | 58,962.000
RPS | P/RPS
3.54 Cent | 9.18
EPS | P/E | EY
1.21 Cent | 26.85 | 3.72%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
2.5% | 16.36%
NP Margin | ROE
35.04% | 30.50%
F.Y. | Ann. Date
30-Nov-2024 | 21-Jan-2025
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Total Positive Profit Years | 4 / 4 | 100.00% | 5 / 8 | 62.50% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 5 / 8 | 62.50% |
Continuous Quarters Of Profit Growth | 4 / 4 | 100.00% | 5 / 8 | 62.50% |
Continuous Quarters Of Adjusted EPS Growth | 4 / 4 | 100.00% | 5 / 8 | 62.50% |
Total Dividend Years | 2 / 4 | 50.00% | 3 / 8 | 38.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | 13.15% | 8.27% | ||
Average Net Profit Margin | 33.64% | 20.86% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Total Positive Profit Years | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Continuous Quarters Of Positive Profit | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Continuous Quarters Of Profit Growth | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Continuous Quarters Of Adjusted EPS Growth | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Total Dividend Years | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Continuous Quarters Of Dividend | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Continuous Quarters Of Dividend Growth | 0 / 2 | 0.00% | 0 / 2 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 1 / 2 | 50.00% | 1 / 2 | 50.00% |
Average ROE | 13.62% | 13.62% | ||
Average Net Profit Margin | 16.13% | 16.13% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 173,687 | 172,478 | 167,586 | 83,793 | 83,793 |
NP to SH | 57,078 | 58,962 | 52,933 | 26,466 | 26,466 |
Dividend | 43,897 | 43,496 | 34,019 | 17,009 | 17,009 |
Adjusted EPS | 1.17 | 1.21 | 1.09 | 0.54 | 0.54 |
Adjusted DPS | 0.90 | 0.89 | 0.70 | 0.35 | 0.35 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | 0.58% | 12.20% | 7.61% | -0.41% | 63.01% |
NP to Owner | 5.00% | 23.63% | 16.36% | 5.82% | 74.33% |
Dividend | 0.00% | 0.00% | 130.37% | 0.00% | 0.00% |
Adjusted EPS | 5.00% | 23.63% | 16.36% | 5.82% | 74.33% |
Adjusted DPS | 0.00% | 0.00% | 130.37% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 3.64% | 107.28% | 107.28% | 2.92% | 105.84% | 105.84% | 0.00% | 100.00% | 100.00% |
NP to Owner | 7.83% | 115.66% | 115.66% | 11.39% | 122.78% | 122.78% | 0.00% | 100.00% | 100.00% |
Dividend | 29.04% | 158.07% | 158.07% | 27.86% | 155.71% | 155.71% | 0.00% | 100.00% | 100.00% |
Adjusted EPS | 7.67% | 115.33% | 115.33% | 11.39% | 122.78% | 122.78% | 0.00% | 100.00% | 100.00% |
Adjusted DPS | 28.86% | 157.72% | 157.72% | 27.86% | 155.71% | 155.71% | 0.00% | 100.00% | 100.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Alpha does show a small rebound. Let's see if it can close at 35 cents today.
Happy 2025 🤗
3 weeks ago
CMO, not COO - In January 2024, Tan joined Alpha IVF as our Group Chief Marketing Officer where he assumed his current responsibilities.
https://alphaivfgroup.com/tan-kay-pau/
2 weeks ago
Alpha IVF Group Bhd has appointed three prominent fertility specialists to strengthen its medical team at the Singapore IVF Centre, with increased demand for advanced fertility treatment due to Singapore's historic low fertility rate of 0.97 in 2023
The newly appointed specialists include Dr. Yu Su Ling, Dr. Chua Ka-Hee, and Dr. Lily Kho Chye Lee, bring decades of expertise in reproductive medicine, IVF, and women’s health.
2 weeks ago
@CASHewnut. Still 2024? Already 2025 lor, Mr Tan appointed as Group Chief Operating Officer (COO) lor
2 weeks ago
drifting to the sky.... alpha 0.40.... Powerhouse of Healthcare in SEA soon
2 weeks ago
Alpha IVF Group Bhd and Duopharma Biotech Bhd are IB’s top picks in the large healthcare sector, along with IHH and KPJ
https://www.thestar.com.my/business/business-news/2025/01/03/elevated-valuations-seen-to-affect-healthcare-stocks
1 week ago
The buying volume is strong, and the momentum is positive. Just wait for the imminent surge!
1 week ago
so hard to push up even with those volume, at least alpha is building up the momentum
1 week ago
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3514931
I followed Dr. Lee and bought at 33.5 cents
1 week ago
only half sen? dream higher la, I wish their business is good so we can get more dividend
6 days ago
still havent meet the criteria also, earliest also 2026 only can transfer to main board
4 days ago
Dr. Lee bought again. Strong support will be formed at 32 cents
https://klse.i3investor.com/web/insider/detail/D_183655_946568881
6 hours ago
ryoyagod
Shareholders are getting dividends tomorrow. There may be a rebound
3 weeks ago